BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 31438880)

  • 1. Comparison of Sanger sequencing for hepatitis C virus genotyping with a commercial line probe assay in a tertiary hospital.
    Goletti S; Zuyten S; Goeminne L; Verhofstede C; Rodriguez-Villalobos H; Bodeus M; Stärkel P; Horsmans Y; Kabamba-Mukadi B
    BMC Infect Dis; 2019 Aug; 19(1):738. PubMed ID: 31438880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of hepatitis C virus subtyping by ns5b sequencing with 5'utr based methods.
    Pagani E; Huemer HP; Pasquetto V; Cemin C; Molon L; Rossi P; Larcher C
    Minerva Med; 2012 Aug; 103(4):293-7. PubMed ID: 22805621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of cobas HCV GT against Versant HCV Genotype 2.0 (LiPA) with confirmation by Sanger sequencing.
    Yusrina F; Chua CW; Lee CK; Chiu L; Png TS; Khoo MJ; Yan G; Lee GH; Yan B; Lee HK
    J Virol Methods; 2018 May; 255():8-13. PubMed ID: 29428399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the Abbott realtime HCV genotype II RUO (GT II) assay with reference to 5'UTR, core and NS5B sequencing.
    Mallory MA; Lucic DX; Sears MT; Cloherty GA; Hillyard DR
    J Clin Virol; 2014 May; 60(1):22-6. PubMed ID: 24656214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotyping hepatitis C viruses from Southeast Asia by a novel line probe assay that simultaneously detects core and 5' untranslated regions.
    Noppornpanth S; Sablon E; De Nys K; Truong XL; Brouwer J; Van Brussel M; Smits SL; Poovorawan Y; Osterhaus AD; Haagmans BL
    J Clin Microbiol; 2006 Nov; 44(11):3969-74. PubMed ID: 16957039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of direct sequencing of the NS5B region with the Versant HCV genotype 2.0 assay for genotyping of viral isolates in Mexico.
    Uribe-Noguez LA; Mata-Marín JA; Ocaña-Mondragón A; Pompa-Mera EN; Ribas-Aparicio RM; Arroyo-Anduiza CI; Gomez-Torres ME; Chaparro-Sánchez A; Gaytán-Martínez J; Mauss S
    J Infect Chemother; 2020 Feb; 26(2):205-210. PubMed ID: 31537472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequencing assays for failed genotyping with the versant hepatitis C virus genotype assay (LiPA), version 2.0.
    Larrat S; Poveda JD; Coudret C; Fusillier K; Magnat N; Signori-Schmuck A; Thibault V; Morand P
    J Clin Microbiol; 2013 Sep; 51(9):2815-21. PubMed ID: 23616453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Versant hepatitis C virus genotype assay (LiPA) 2.0.
    Verbeeck J; Stanley MJ; Shieh J; Celis L; Huyck E; Wollants E; Morimoto J; Farrior A; Sablon E; Jankowski-Hennig M; Schaper C; Johnson P; Van Ranst M; Van Brussel M
    J Clin Microbiol; 2008 Jun; 46(6):1901-6. PubMed ID: 18400913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Abbott RealTime HCV Genotype II with Versant line probe assay 2.0 for hepatitis C virus genotyping.
    Liu CH; Liang CC; Liu CJ; Lin CL; Su TH; Yang HC; Chen PJ; Chen DS; Kao JH
    J Clin Microbiol; 2015 May; 53(5):1754-7. PubMed ID: 25740780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful HCV genotyping of previously failed and low viral load specimens using an HCV RNA qualitative assay based on transcription-mediated amplification in conjunction with the line probe assay.
    Comanor L; Elkin C; Leung K; Krajden M; Kronquist K; Nicolas K; Horansky E; deMedina M; Kittichai P; Sablon E; Ziermann R; Sherlock C
    J Clin Virol; 2003 Sep; 28(1):14-26. PubMed ID: 12927747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 6 HCV genotyping 9G test and its comparison with VERSANT HCV genotype 2.0 assay (LiPA) for the hepatitis C virus genotyping.
    Chantratita W; Song KS; GunHo C; Pongthanapisith V; Thongbaiphet N; Wongtabtim G; Pasomsub E; Angkanavin K; Nimse SB; Sonawane MD; Warkad SD; Kim T
    J Virol Methods; 2017 Jan; 239():1-8. PubMed ID: 27793646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of sequencing of HCV core/E1, NS5A and NS5B as a genotype predictive tool in comparison with commercial assays targeting 5'UTR.
    McCormick AL; Macartney MJ; Abdi-Abshir I; Labbett W; Smith C; Irish D; Webster DP; Haque T
    J Clin Virol; 2015 May; 66():56-9. PubMed ID: 25866338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance comparison of the versant HCV genotype 2.0 assay (LiPA) and the abbott realtime HCV genotype II assay for detecting hepatitis C virus genotype 6.
    Yang R; Cong X; Du S; Fei R; Rao H; Wei L
    J Clin Microbiol; 2014 Oct; 52(10):3685-92. PubMed ID: 25100817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of hepatitis C virus (HCV) genotype determination with the new version of the INNO-LiPA HCV assay.
    Bouchardeau F; Cantaloube JF; Chevaliez S; Portal C; Razer A; Lefrère JJ; Pawlotsky JM; De Micco P; Laperche S
    J Clin Microbiol; 2007 Apr; 45(4):1140-5. PubMed ID: 17251399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two unusual hepatitis C virus subtypes, 2j and 2q, in Spain: Identification by nested-PCR and sequencing of a NS5B region.
    Margall N; March F; Español M; Torras X; Gallego A; Coll P
    J Virol Methods; 2015 Oct; 223():105-8. PubMed ID: 26253334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcription-mediated amplification linked to line probe assay as a routine tool for HCV typing in clinical laboratories.
    Ross RS; Viazov S; Kpakiwa SS; Roggendorf M
    J Clin Lab Anal; 2007; 21(5):340-7. PubMed ID: 17847116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotyping hepatitis C virus from hemodialysis patients in Central Brazil by line probe assay and sequence analysis.
    Espírito-Santo MP; Carneiro MA; Reis NR; Kozlowski AG; Teles SA; Lampe E; Yoshida CF; Martins RM
    Braz J Med Biol Res; 2007 Apr; 40(4):545-50. PubMed ID: 17401498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative performance evaluation of hepatitis C virus genotyping based on the 5' untranslated region versus partial sequencing of the NS5B region of brazilian patients with chronic hepatitis C.
    Nakatani SM; Santos CA; Riediger IN; Krieger MA; Duarte CA; do Carmo Debur M; Carrilho FJ; Ono SK
    Virol J; 2011 Oct; 8():459. PubMed ID: 21967749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of molecular methods for identification of unusual subtypes of hepatitis C virus genotype 2.
    D'Angelo P; Jaspe RC; Loureiro CL; Gutiérrez C; Sulbarán MZ; Sulbarán Y; Toro F; Pujol FH
    Biomedica; 2018 Jun; 38(2):282-288. PubMed ID: 30184351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Three Different Hepatitis C Virus Genotyping Methods: 5'NCR PCR-RFLP, Core Type-Specific PCR, and NS5b Sequencing in a Tertiary Care Hospital in South India.
    Daniel HD; David J; Raghuraman S; Gnanamony M; Chandy GM; Sridharan G; Abraham P
    J Clin Lab Anal; 2017 May; 31(3):. PubMed ID: 27580956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.